Search Results - "Ginderachter, Jo"

Refine Results
  1. 1

    Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity by Casazza, Andrea, Laoui, Damya, Wenes, Mathias, Rizzolio, Sabrina, Bassani, Nicklas, Mambretti, Marco, Deschoemaeker, Sofie, Van Ginderachter, Jo A., Tamagnone, Luca, Mazzone, Massimiliano

    Published in Cancer cell (09-12-2013)
    “…Recruitment of tumor-associated macrophages (TAMs) into avascular areas sustains tumor progression; however, the underlying guidance mechanisms are unknown…”
    Get full text
    Journal Article
  2. 2

    Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies by Pombo Antunes, Ana Rita, Scheyltjens, Isabelle, Duerinck, Johnny, Neyns, Bart, Movahedi, Kiavash, Van Ginderachter, Jo A

    Published in eLife (04-02-2020)
    “…Cancer immunotherapy by immune checkpoint blockade has proven its great potential by saving the lives of a proportion of late stage patients with immunogenic…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    The Heat Is On: 20-HETE Instructs an Immunosuppressive Phenotype in Cancer-Associated Fibroblasts by Van Ginderachter, Jo A.

    Published in Cancer research (Chicago, Ill.) (02-11-2022)
    “…Immunotherapy of cancer is a burgeoning field of research since the realization that our immune system intrinsically has the capacity to restrict tumor…”
    Get full text
    Journal Article
  6. 6

    The Ontogeny and Microenvironmental Regulation of Tumor-Associated Macrophages by Movahedi, Kiavash, Van Ginderachter, Jo A

    Published in Antioxidants & redox signaling (10-11-2016)
    “…Tumor progression is supported by non-cancerous stromal cells, of which tumor-associated macrophages (TAMs) are prominent constituents. These cells could be…”
    Get more information
    Journal Article
  7. 7

    Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity by Geeraerts, Xenia, Bolli, Evangelia, Fendt, Sarah-Maria, Van Ginderachter, Jo A

    Published in Frontiers in immunology (15-03-2017)
    “…Macrophages are not only essential components of innate immunity that contribute to host defense against infections, but also tumor growth and the maintenance…”
    Get full text
    Journal Article
  8. 8

    Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment by Lahmar, Qods, Keirsse, Jiri, Laoui, Damya, Movahedi, Kiavash, Van Overmeire, Eva, Van Ginderachter, Jo A.

    Published in Biochimica et biophysica acta (01-01-2016)
    “…The tumor-promoting role of macrophages has been firmly established in most cancer types. However, macrophage identity has been a matter of debate, since…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Tumor‐induced myeloid‐derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T‐cell activation events by Schouppe, Elio, Mommer, Camille, Movahedi, Kiavash, Laoui, Damya, Morias, Yannick, Gysemans, Conny, Luyckx, Ariane, De Baetselier, Patrick, Ginderachter, Jo A.

    Published in European journal of immunology (01-11-2013)
    “…Tumor growth coincides with an accumulation of myeloid‐derived suppressor cells (MDSCs), which exert immune suppression and which consist of two main…”
    Get full text
    Journal Article
  11. 11

    Novel insights in the regulation and function of macrophages in the tumor microenvironment by Bolli, Evangelia, Movahedi, Kiavash, Laoui, Damya, Van Ginderachter, Jo A

    Published in Current opinion in oncology (01-01-2017)
    “…PURPOSE OF REVIEWTumors contain not only cancer cells but also nontransformed types of cells, the stromal cells. A bidirectional interplay exists between…”
    Get full text
    Journal Article
  12. 12

    How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions by Bruger, Annika M., Dorhoi, Anca, Esendagli, Gunes, Barczyk-Kahlert, Katarzyna, van der Bruggen, Pierre, Lipoldova, Marie, Perecko, Tomas, Santibanez, Juan, Saraiva, Margarida, Van Ginderachter, Jo A., Brandau, Sven

    Published in Cancer Immunology, Immunotherapy (01-04-2019)
    “…Myeloid-derived suppressor cells (MDSC) are a heterogeneous group of mononuclear and polymorphonuclear myeloid cells, which are present at very low numbers in…”
    Get full text
    Journal Article
  13. 13

    Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell–suppressive activity by Movahedi, Kiavash, Guilliams, Martin, Van den Bossche, Jan, Van den Bergh, Rafael, Gysemans, Conny, Beschin, Alain, De Baetselier, Patrick, Van Ginderachter, Jo A.

    Published in Blood (15-04-2008)
    “…The induction of CD11b+Gr-1+ myeloid-derived suppressor cells (MDSCs) is an important immune-evading mechanism used by tumors. However, the exact nature and…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Acute injury in the peripheral nervous system triggers an alternative macrophage response by Ydens, Elke, Cauwels, Anje, Asselbergh, Bob, Goethals, Sofie, Peeraer, Lieve, Lornet, Guillaume, Almeida-Souza, Leonardo, Van Ginderachter, Jo A, Timmerman, Vincent, Janssens, Sophie

    Published in Journal of neuroinflammation (20-07-2012)
    “…The activation of the immune system in neurodegeneration has detrimental as well as beneficial effects. Which aspects of this immune response aggravate the…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20